Should You Buy the Dip in fuboTV?

: FUBO | fuboTV Inc. News, Ratings, and Charts

FUBO – fuboTV Inc. (FUBO), a live sports and entertainment streaming platform, saw its shares tumble 37.3% over the past month, due primarily to investors’ concerns over the company’s increasing losses and expenses. But the question is, as the TV streaming space gets heated with the arrival of more services, will FUBO be able to survive and thrive? Read on to learn more.

The live TV streaming platform fuboTV Inc. (FUBO) has seen its stock price tumble 29.6% year-to-date and 37.3% over the past month. In fact, the stock is currently trading at $19.71, nearly 70% below its 52-week high of $62.29, which it hit on December 22. 

Although FUBO has gained 181.6% over the past year, due primarily to a significant growth in subscription, it reported a huge net loss for 2020. Moreover, the company’s high operating costs and broadcasting expenses are causing its expenditures to outweigh its revenue generation. 

In an increasingly crowded streaming space, FUBO remains unprofitable. And even though the company remains focused on growing its subscription base by investing in new content, it faces immense competition from TV streaming titans, such as Disney+ and YouTube TV. So, we think the stock could witness a further price retreat. 

Here is what we think could influence FUBO’s performance in the near term:

Competitive TV Streaming Market

A TV streaming war has hit a new level of competition with the launch of more services by entertainment titans, including  Disney+, YouTube TV, AppleTV Plus, and Hulu. These household name brands are offering an increasing array of content choices to their customers at affordable prices. Amid this environment, FUBO’s loss making business and limited customer base could be a real challenge to the company’s efforts to stay afloat.

Increasing losses and Expenses

FUBO’s subscription revenue increased 91% year-over-year to $91.4 million in the fourth quarter ended December 31, 2020. However, its $89.9 million in subscriber-related expenses represented a 42.5% year-over-year increase. Its total operating expenses were $197.4 million, compared to $18.24 million in the prior-year quarter. FUBO reported an adjusted EBITDA of negative $43.5 million. The company reported an operating loss of $92.32 million and a net loss of $167.83 million. Its loss per share was $2.47, compared to $1.07 in the fourth quarter of 2019.

Low Profitability

The company’s trailing-12-month CAPEX/Sales of 0.08% is 96.9% lower than the industry average 2.4%. FUBO’s 0.3% asset turnover ratio is 44% lower than the industry average 0.6%. And  its trailing-12-month gross profit margin and EBIT margin came in at negative 7.4% and 106.1%, respectively.

POWR Ratings Reflect Bleak Outlook

FUBO has a D overall rating, which translates to Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree. 

Our proprietary rating system also evaluates each stock based on eight different categories. FUBO has a D Quality Grade, given the stock’s weak profitability.

In terms of Value Grade, FUBO has a D. This justifies the stock’s trailing-12-month EV/Sales of 13.31x, which is 188.2% higher than the industry average of 4.62x.

It also  has a D grade for Stability, given that it is more volatile compared to its peers.

Beyond what we’ve stated above, one can view additional FUBO ratings for Growth, Sentiment, and Momentum here.

Of the 13 stocks in the F-rated Entertainment – Sports & Theme Parks industry, FUBO is ranked #8.

 Click here to view the top-rated stocks in the same industry. 

Bottom Line

Given the competitive streaming landscape, FUBO’s lower profitability and increasing losses might retard its growth in the near term. Even its increasing user base will not be sufficient to propel its growth if its subscriber-related expenses and broadcasting expenses continue increasing. So, we think the recent price dip does not provide a good entry point in the stock.

  


FUBO shares were trading at $20.09 per share on Thursday morning, up $0.38 (+1.93%). Year-to-date, FUBO has declined -28.25%, versus a 11.46% rise in the benchmark S&P 500 index during the same period.


About the Author: Imon Ghosh


Imon is an investment analyst and journalist with an enthusiasm for financial research and writing. She began her career at Kantar IMRB, a leading market research and consumer consulting organization. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
FUBOGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Top 4 Tech Giants Poised for Explosive Growth

Fueled by the ever-growing demand for advanced technological solutions across various sectors and ongoing innovation, the tech industry has robust growth prospects. Thus, it could be wise to invest in top tech stocks Dropbox (DBX), TTM Technologies (TTMI), Lantronix (LTRX) and AstroNova (ALOT) for potential growth. Continue reading…

3 Top Rated Software Stocks to Streamline Your Investments

The software industry is thriving with soaring demand, presenting ample investment opportunities. So, fundamentally solid software stocks ServiceNow (NOW), Autodesk (ADSK), and Docebo (DCBO) might be ideal buys for promising returns. Read on...

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading...

Investor Alert: “Buy the Rumor, Sell the News!”

Everyone knows that the Fed is going to cut rates at some point this year. That is the worst kept secret on the planet helping to explain how we keep making new highs for the for the S&P 500 (SPY). Unfortunately that creates an interesting predicament for stocks after rates are cut. Plus another hurdle in the 2024 Presidential election. Steve Reitmeister is here to share his insights on the market outlook along with a preview of his top 12 stocks to outperform. Read on for more...

Read More Stories

More fuboTV Inc. (FUBO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All FUBO News